Symptom Assessment With Patient Surveys

This study has been completed.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT01135823
First received: June 1, 2010
Last updated: June 2, 2010
Last verified: June 2010
  Purpose

The primary purpose of the proposed research is to explore methods of obtaining symptom assessments from pediatric oncology patients and/or their caregivers in hopes of improving the accuracy and thoroughness of these reports. Additionally the researchers hope to simply staff efforts in obtaining detailed medical histories from pediatric oncology patients.


Condition Intervention
Carcinomas
Squamous Cell Carcinoma
Adenocarcinoma
Procedure: Patient survey

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Symptom Assessment With Patient Surveys

Further study details as provided by Stanford University:

Estimated Enrollment: 100
Study Start Date: July 2006
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

These patients will be pediatric oncology patients who have received chemotherapy within the prior four weeks and being seen in the oncology clinic for an out-patient visit.

Criteria

Inclusion Criteria:

  • Approximately 150 patients ages 0-18 years (75 for each group-intervention and control) will be enrolled.
  • These patients will be pediatric oncology patients who have received chemotherapy within the prior four weeks and being seen in the oncology clinic for an out-patient visit.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01135823

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Christina Baggott NP RN Stanford University
  More Information

No publications provided

Responsible Party: Christina Baggott NP RN, Stanford University School of Medicine
ClinicalTrials.gov Identifier: NCT01135823     History of Changes
Other Study ID Numbers: SU-07292009-3461, 97085, PEDSVAR0001
Study First Received: June 1, 2010
Last Updated: June 2, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Adenocarcinoma
Carcinoma
Carcinoma, Squamous Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell

ClinicalTrials.gov processed this record on July 23, 2014